Glucagon-Like Peptide I (7-36), amide, human
Not For Human Use, Lab Use Only.
Cat.#: 300478
Special Price 293.40 USD
-
Product Name
Glucagon-Like Peptide I (7-36), amide, human
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR
-
Sequence
H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
-
Length (aa)
30
-
Peptide Purity (HPLC)
95.9%
-
Molecular Formula
C149H226N40O45
-
Molecular Weight
3297.68
-
CAS No.
123475-27-4
-
Source
Synthetic
-
Form
Powder
-
Description
Glucagon-Like Peptide I (7-36), amide, human, is a bioactive peptide hormone derived from the preproglucagon gene. It is secreted by intestinal L-cells in response to nutrient ingestion and plays a critical role in glucose homeostasis by enhancing insulin secretion and suppressing glucagon release. The peptide exerts its effects through binding to the GLP-1 receptor, a G-protein-coupled receptor widely expressed in pancreatic islets, the central nervous system, and other peripheral tissues.
The sequence of GLP-1 (7-36) amide consists of 30 amino acids, featuring key structural motifs essential for receptor binding and biological activity. It is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), resulting in a short plasma half-life. Despite its transient presence, GLP-1 (7-36) amide significantly influences energy metabolism, including the regulation of gastric emptying and satiety, through both peripheral and central mechanisms.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- G.I.Bell et al., Nature, 304, 368 (1983)
- B.Kreymann et al., Lancet, 2, 1300 (1987)
- C.Orskov and J.H.Nielsen, FEBS Lett., 229, 175 (1988)
- J.-P.Raufman et al., J. Biol. Chem., 267, 21432 (1992)
- P.A.Martin and A.Faulkner, Comp. Biochem. Biophys., 105A, 705 (1993)
- H.C.Fehmann et al., Peptides, 15, 453 (1994)
- M.A.Nauck et al., Exp. Clin. Endocrinol. Diabetes, 105, 187 (1997)
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
-
Molar Concentration Calculator
-
Dilution Calculator
-
Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"